The North American Thrombosis Forum (NATF)

The North American Thrombosis Forum (NATF) is a nonprofit organization dedicated to improving the lives of those affected by blood clots and related diseases. Through our comprehensive resources and innovative programming, we strive to educate patients and healthcare providers about thrombosis and its complications.

Join NATF in the fight against blood clots. You can make a donation here!

 

The North American Thrombosis Forum (NATF)
Avatar

Novel Trials and Guideline Updates from the 2020 ESC Congress: When to Use Empagliflozin, Dapagliflozin and Antiarrhythmic Drugs? What Are the Guidelines for Patients with AFib and Elective PCI or ACS? When to Perform Catheter Ablation?

By The North American Thrombosis Forum (NATF) FEATURING Christian Ruff
By The North American Thrombosis Forum (NATF) FEATURING Christian Ruff
0 views
October 15, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Videos
16:25
The North American Thrombosis Forum (NATF)

An Internist's Perspective: Understanding Obesity and it's…

Feat. J. Shiau
15:21
The North American Thrombosis Forum (NATF)

A Cardiologist's Perspective: How I Treat My Patients with Obes…

Feat. A. Aday
19:42
The North American Thrombosis Forum (NATF)

How I Treat My Patients with Obesity and VTE - A Hematologist's…

Feat. T. Wang
15:17
The North American Thrombosis Forum (NATF)

A Surgeon's Perspective: How I Treat My Anticoagulated Patients…

Feat. M. Robinson
17:12
The North American Thrombosis Forum (NATF)

Case Presentation: DOAC Use in a Patient with Obesity and Atrial Fib…

Feat. A. Aday
11:08
The North American Thrombosis Forum (NATF)

Case Presentation: What Anticoagulant a Hematologst Recommends to an…

Feat. T. Wang
10:26
The North American Thrombosis Forum (NATF)

Case Presentation: How I Treat My Anticoagulated Patients Undergoing…

Feat. M. Robinson
60:52
The North American Thrombosis Forum (NATF)

Current Treatments for LDL Lowering — and Why Patient Access Is So I…

Feat. J. Plutzky, H. Johnson, S. Martin
59:01
The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross
58:26
The North American Thrombosis Forum (NATF)

The Critical Importance of Lowering LDL-C in High-Risk Patients

Feat. A. Taylor, T. Gluckman, M. Minissian
58:08
The North American Thrombosis Forum (NATF)

Identifying Patients Who Would Benefit from PCSK9 Inhibitors

Feat. A. Taylor, J. Plutzky, A. Saeed
20:38
The North American Thrombosis Forum (NATF)

Heart Disease and Thrombosis in Pregnancy

Feat. K. Lindley
05:26
The North American Thrombosis Forum (NATF)

COVID-19 and Blood Clots: 2022 Update

Feat. B. Bikdeli
05:21
The North American Thrombosis Forum (NATF)

Clot Chronicles: Trial Takeaways from AHA 2021

Feat. C. Cruff
05:13
The North American Thrombosis Forum (NATF)

Clot Chronicles: The SLICE Trial - Significance of Pulmonary Embolis…

Feat. D. Jiménez
20:29
The North American Thrombosis Forum (NATF)

What the Heck Is CTEPH?

Feat. W. Auger
14:07
The North American Thrombosis Forum (NATF)

Clot Chronicles: Trial Takeaways from ESC 2021

Feat. C. Cruff
06:05
The North American Thrombosis Forum (NATF)

The Perils of Discontinuing Anticoagulation in Afib — Findings from …

Feat. S. Goldhaber
09:19
The North American Thrombosis Forum (NATF)

Clot Chronicles: Peripheral Artery Disease — What Clinicians Should …

Feat. M. Mcdermott
11:35
The North American Thrombosis Forum (NATF)

Stroke in Women: Can HTN, Diabetes and AFib Increase the Risk for St…

Feat. K. Rexrode
25:06
The North American Thrombosis Forum (NATF)

Women's Cardiovascular Health: How to Evaluate D-dimer Tests in…

Feat. K. Mikkelsen, G. Piazza, M. Wood, K. Rexrode, M. Minissian, A. Valente
20:39
The North American Thrombosis Forum (NATF)

Management of Women with Cardiovascular Diseases: How to Treat Patie…

Feat. G. Piazza
14:37
The North American Thrombosis Forum (NATF)

Diagnosis and Management of Acute Coronary Syndrome in Women: What A…

Feat. M. Minissian
16:18
The North American Thrombosis Forum (NATF)

The Challenge of Nonatherosclerotic Coronary Disease: How to Diagnos…

Feat. M. Wood
14:28
The North American Thrombosis Forum (NATF)

Thrombosis and Hypercoagulable States in Young Women: How to Manage …

Feat. G. Piazza
16:00
The North American Thrombosis Forum (NATF)

Structural Heart Disease in Pregnant Women: Risk Stratification and …

Feat. A. Valente
05:38
The North American Thrombosis Forum (NATF)

Vitamin D: How Does It Work? What's the “Right” Level?

Feat. C. J. Rosen
05:57
The North American Thrombosis Forum (NATF)

Vitamin D Myths & Realities: Can Vitamin D Levels Predict Chroni…

Feat. C. J. Rosen
07:42
The North American Thrombosis Forum (NATF)

Vitamin D for Acute/Chronic Diseases: How Does It Impact CVD, Thromb…

Feat. C. J. Rosen
09:43
The North American Thrombosis Forum (NATF)

AHA 2020 Trial Takeaways: Should Rivaroxaban Be Used in Patients wit…

Feat. C. Ruff
13:21
The North American Thrombosis Forum (NATF)

Novel Trials and Guideline Updates from the 2020 ESC Congress: When …

Feat. C. Ruff
05:34
The North American Thrombosis Forum (NATF)

Bleeding & Thrombosis in COVID-19: Does Anticoagulation Strategy…

Feat. H. Al-Samkari
04:52
The North American Thrombosis Forum (NATF)

Cardiovascular Disease in Women: Are Women Less Likely to Be Prescri…

Feat. M. Wood